Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REFORM-HF™ Reducing Fluid Overload Using Renal Independent systeM in Heart Failure Patients

NCT06360380 is registered in ClinicalTrials.gov with AquaPass Medical Ltd. as lead sponsor.

NCT NCT06360380
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06360380 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REFORM-HF™ Reducing Fluid Overload Using Renal Independent systeM in Heart Failure Patients
Lead sponsor
AquaPass Medical Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
August 12, 2024
Completion date
April 30, 2027
Enrollment
40 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

chronic heart failure, ckd stage 3